A Phase III Study of Entecavir vs Lamivudine in Adults With Chronic Hepatitis B Infection and Negative for Hepatitis B e Antigen

PHASE3CompletedINTERVENTIONAL
Timeline

Start Date

November 30, 2001

Primary Completion Date

May 31, 2005

Study Completion Date

May 31, 2005

Conditions
Chronic Hepatitis B
Interventions
DRUG

Entecavir

Trial Locations (31)

30322

Local Investigator, Atlanta

37211

Local Investigator, Nashville

60622

Local Investigator, Chicago

90048

Local Investigator, Los Angeles

Unknown

Local Investigator, Birmingham

Local Investigator, Tucson

Local Investigator, La Jolla

Local Investigator, Orange

Local Investigator, San Francisco

Local Investigator, Farmington

Local Investigator, Miami Beach

Local Investigator, Honolulu

Local Investigator, Iowa City

Local Investigator, Kansas City

Local Investigator, Dundalk

Local Investigator, Worcester

Local Investigator, Ann Arbor

Local Investigator, Royal Oak

Local Investigator, Saint Paul

Local Investigator, Manhasset

Local Investigator, New York

Local Investigator, Rochester

Local Investigator, Charlotte

Local Investigator, Cleveland

Local Investigator, Philadelphia

Local Investigator, Pittsburgh

Local Investigator, Providence

Local Investigator, Dallas

Local Investigator, Fairfax

Local Investigator, Richmond

Local Investigator, Seattle

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY